Undervalued Dividend Stocks with Growth Potential

Aug.12.2022
Undervalued Dividend Stocks with Growth Potential
Undervalued stocks with potential for strong rebound, including Altria (MO) and Pfizer (PFE). AT&T and Lockheed Martin also highlighted.

Several undervalued stocks are expected to experience a strong rebound in the coming months, including Altria.


Tobacco company Altria (ticker symbol MO)


Source: Kristi Blokhin / Shutterstock.com


Even after the trouble with Juul, the e-cigarette manufacturer, it appears that Altria (NYSE stock code: MO) is still undervalued. Over the past year, the stock has fallen by about 6%, with a forward valuation of only 9.3 times. At the same time, the stock's yield is as high as 8.1%.


Altria is increasing its focus on its non-combustible business, and its investments will be concentrated in this area over the next few years. However, the combustible portion of the business remains the driving force of cash flow. In the second quarter, its Marlboro brand cigarettes held 42.7% of the entire cigarette market.


It is important to note that Altria holds a 45% stake in Cronos (NASDAQ stock code: CRON). Federal legalization of cannabis would serve as a significant catalyst for CRON stock and benefit Altria.


Pfizer: This pharmaceutical company is not merely a one-trick pony, as Wall Street may have believed.


AT&T: $14 billion in free cash flow should provide enough flexibility for dividends and debt repayment.


Lockheed Martin Corporation (LMT) has stated that its backlog of orders worth $135 billion may increase due to the escalating geopolitical tensions.


Altria (MO) stock is currently undervalued with a yield of 8%, even after deducting regulatory factors related to JUUL.


Source: Pisit.Sj / Shutterstock.com


Generally speaking, the main reason for holding dividend stocks is to generate regular cash flow. In addition, dividend stocks are typically low beta stocks, which can help balance overall portfolio risk. However, this does not mean that dividend stocks cannot produce healthy capital gains.


Over the past decade, the Standard and Poor's 500 High Dividend Index has had an annualized price return rate of 6.95%, while the total annualized return rate has been 8.86%. It is evident that the price return has been strong.


As global markets face uncertainty related to inflation and recession, several dividend stocks have been revised and are trading at attractive valuations. These high-quality blue-chip stocks are simply a matter of time before they fill the valuation gap. In doing so, they may outperform the broader market.


By investing in the following four dividend-paying stocks, investors can position themselves for stable income and meaningful appreciation. Given the growth prospects for the underlying companies' revenue and profits, these dividend-paying stocks are worth holding for the long term.


Pfizer (PFE)


Source: photobyphm / Shutterstock.com


Pfizer (NYSE: PFE) is one of the most attractive dividend stocks to purchase due to its low beta, strong 3.2% yield, and undervaluation. Over the past 12 months, PFE's stock price has only increased by less than 1%. Its forward P/E ratio is just 7.8, indicating significant potential for growth.


One reason for Pfizer's underperformance is investors' concerns over potential revenue declines in Covid-19 vaccine sales. However, the company's growth story is not solely tied to Covid-19. Pfizer boasts a rich pipeline of drugs, and as new candidates become commercialized, they will drive sales growth.


Pfizer generated $29.9 billion in free cash flow in 2021, which has allowed them to increase investments in research and development. At the same time, the company has been active on the acquisition front in recent quarters.


The PFE stock appears poised for an upward trend. Investors may take some risks to quickly gain capital returns in the coming months.


AT&T, one of the largest telecommunications companies in the world, has recently made headlines.


As the business continues to grow and with a forward P/E ratio of 7x, there are compelling reasons for the stock to rise by 20-30% from its current level, in addition to a forward annual yield of 6.2%. This data is sourced from Lester Balajadia / Shutterstock.com.


AT&T has witnessed a continued growth in both 5G and fiber optic users. The company seems poised to benefit from its significant investments in 5G. Currently, its 5G network covers over 255 million people, and it plans to "double its fiber coverage to reach over 300,000 locations.


AT&T has used the proceeds from the split of WarnerMedia to reduce its debt. The positive free cash flow provides flexibility for further debt reduction and dividend payouts. Management anticipates this year's free cash flow to be $14 billion USD.


Lockheed Martin Corporation (LMT)


Source: Ken Wolter/Shutterstock.com


The stock price of Lockheed Martin Corporation (NYSE: LMT) has increased by 11.5% over the past six months. However, considering its forward price-to-earnings ratio of 16.1 and dividend yield of 2.6%, the stock appears to be undervalued.


The escalation of geopolitical tensions has made the defense sector attractive. As of June 26th, Lockheed Martin, with a backlog of almost $135 billion in orders, is in a favorable position to generate profits. The backlog provides cash flow visibility for the next 12 to 24 months.


Furthermore, I anticipate that the backlog of orders will increase in the coming quarters. Many European countries have failed to meet their defense spending targets. With the escalation of tension in the region, higher defense spending will benefit Lockheed Martin Corporation.


With a steady and healthy free cash flow, Lockheed's dividend is sustainable. The company reported a free cash flow of $1 billion in the second quarter of 2022, and management anticipates a free cash flow of approximately $6 billion for the year.


Statement:


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The compilation of this article is intended solely for industry discussion and research purposes.


Due to limitations in our compiling abilities, the compiled article may not fully express the same meaning as the original text. Therefore, please refer to the original article for accuracy.


2FIRSTS fully aligns its statements and positions with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and international issues.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

2FIRSTS EXCLUSIVE|China Breaks Up $6.8 Million Illegal Hookah Tobacco Operation as Market Expands
2FIRSTS EXCLUSIVE|China Breaks Up $6.8 Million Illegal Hookah Tobacco Operation as Market Expands
Chinese authorities have dismantled an illegal hookah tobacco operation worth more than 46 million yuan ($6.8 million), detaining five foreign suspects and seizing over 500,000 boxes of tobacco paste. The case comes as hookah expands across China’s nightlife sector and attracts overseas operators, including former vaping entrepreneurs. It also raises a central regulatory question: whether waterpipe tobacco will follow China’s private-sector e-cigarette licensing model or be reserved for the state tobacco system, as with nicotine pouches, in the years ahead.
Jul.31
Italian Court Ends Six-Year Cigarette Excise Dispute, Rejecting Damages Claim
Italian Court Ends Six-Year Cigarette Excise Dispute, Rejecting Damages Claim
Italy’s Lazio Regional Administrative Court has dismissed an appeal by Italian Tobacco Manufacturing and Manifattura Italiana Tabacco over the cigarette excise calculation mechanism, upholding the minimum tax burden rules and excluding compensation for smaller tobacco operators.
News
Jun.26 by 2Firsts Perspectives
BAT New Categories Revenue Rises 18% in H1 2026 as Broad Portfolio Offers More Ways to Win—and Lose
BAT New Categories Revenue Rises 18% in H1 2026 as Broad Portfolio Offers More Ways to Win—and Lose
British American Tobacco’s New Category revenue rose 18% at constant rates in the first half of 2026. Nicotine-pouch brand Velo expanded rapidly, while Vuse recovered as U.S. enforcement against illicit e-vapor products strengthened. Heated-tobacco platform glo remained under pressure, and cigarettes continued to provide most of the group’s profit and cash. Compared with PMI and JT, BAT has more routes to growth—but also greater regulatory, investment and execution risks across its broader portfolio.
BAT
Jul.30
Product | VELO Launches Tomorrowland Limited Edition 2026 as Festival IP Enters Nicotine Pouch Packaging
Product | VELO Launches Tomorrowland Limited Edition 2026 as Festival IP Enters Nicotine Pouch Packaging
BAT’s nicotine pouch brand VELO has introduced the Tomorrowland Limited Edition 2026. Public retail-channel information shows the product has appeared across multiple European online platforms, while Haypp UK has listed related SKUs with a “Coming soon” status. The packaging carries the wording “Official Tomorrowland Partner,” indicating that the collection is part of VELO’s official collaboration with the electronic music festival brand.
Jul.02
Product | APUS Launches Chloe 50K, Bringing Purse-Inspired Design to the U.S. High-Puff Disposable Market
Product | APUS Launches Chloe 50K, Bringing Purse-Inspired Design to the U.S. High-Puff Disposable Market
APUS has introduced the Chloe 50K disposable vape, which has appeared across U.S.-facing online retail channels including Element Vape and Vapesourcing. The device combines a purse-inspired body and chain attachment with a 20ml e-liquid capacity, 1,250mAh rechargeable battery, dual mesh coil, and battery and e-liquid indicators. It is rated for up to 50,000 puffs. The product does not appear on the FDA’s current list of authorized e-cigarettes, and U.S. retail availability does not indicate FDA marketing authorization.
Jul.15
Product | PMI Launches Airport-Exclusive IQOS Skylens Limited Edition, Expanding From Japan’s Narita to Travel Retail Markets in 13 Countries Summary
Product | PMI Launches Airport-Exclusive IQOS Skylens Limited Edition, Expanding From Japan’s Narita to Travel Retail Markets in 13 Countries Summary
Philip Morris International (PMI) has introduced the airport-exclusive limited-edition IQOS ILUMA i PRIME Skylens, the company’s first device created specifically for airport travel retail. Inspired by the world of flight and finished in metallic blue, Skylens debuted at Narita International Airport in Japan before expanding into selected airport duty-free and travel-retail channels across 13 countries in Europe, Asia, the Middle East and Africa. The product retains the existing IQOS ILUMA i PRIME platform, with differentiation centered on airport exclusivity, design and travel-retail execution rather than a new heating architecture.
PMI
Aug.19